Robert Charles Tuckey

13PUBLICATIONS
43CO-AUTHORS
Molecular medicineNonlinear optics and spectroscopyChemical thermodynamics and energeticsMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Apr 13, 2026
Correction: Janjetovic et al. Novel Vitamin D3 Hydroxymetabolites Require Involvement of the Vitamin D Receptor or Retinoic Acid-Related Orphan Receptors for Their Antifibrogenic Activities in Human Fibroblasts. <i>Cells</i> 2024, <i>13</i>, 239.

Zorica Janjetovic, Shariq Qayyum, Sivani B Reddy

|Dec 15, 2025
Is Vitamin D Signaling Regulated by and Does It Regulate Circadian Rhythms?

A T Slominski, R M Slominski, M Kamal

|Mar 07, 2025
The vitamin D<sub>3</sub> hormone, 1,25(OH)<sub>2</sub>D<sub>3</sub>, regulates fibroblast growth factor 23 (FGF23) production in human skin cells.

Franz Ewendt, Zorica Janjetovic, Tae-Kang Kim

|Oct 26, 2024
Anticancer Activity of Vitamin D, Lumisterol and Selected Derivatives against Human Malignant Melanoma Cell Lines.

Paweł Domżalski, Anna Piotrowska, Robert C Tuckey

|Jun 27, 2024
Malignant Melanoma: An Overview, New Perspectives, and Vitamin D Signaling.

Radomir M Slominski, Tae-Kang Kim, Zorica Janjetovic

|Feb 09, 2024
Novel Vitamin D3 Hydroxymetabolites Require Involvement of the Vitamin D Receptor or Retinoic Acid-Related Orphan Receptors for Their Antifibrogenic Activities in Human Fibroblasts.

Zorica Janjetovic, Shariq Qayyum, Sivani B Reddy

Pageof 3

Frequent Collaborators

11 joint publications

Andrzej T Slominski

5 joint publications

Wei Li

5 joint publications

Tae-Kang Kim

4 joint publications

Zorica Janjetovic